Vol 11, No 3 (2017)
Review paper
Published online: 2017-12-21

open access

Page views 680
Article views/downloads 1671
Get Citation

Connect on Social Media

Connect on Social Media

Palliative care in patients with chronic obstructive pulmonary disorder

Iwona Katarzyna Damps-Konstańska1, Rafał Kostrzewski1
Medycyna Paliatywna w Praktyce 2017;11(3):91-95.

Abstract

Palliative and hospice care plays a major role in the treatment of patients with advanced chronic obstructive pulmonary disease (COPD). The treatment involves pharmacotherapy and nonpharmacological methods such as smoking cessation, which may require the implementation of pharmacotherapy, increase levels of physical activity if possible, rehabilitation, oxygen therapy, dietetic recommendations, vaccination against influenza and pneumococci. Patients with COPD, who have dyspnoea despite optimal bronchodilating treatment, with progression of disease leading to exacerbations which require hospitalization or hospital emergency intervention. The aim of the palliative care is the treatment of pain, dyspnoea, cough, chronic fatigue syndrome, anxiety and depression, prevention of exacerbations of disease, as well as, comprehensive psychosocial and spiritual support of patients and caregivers.

Article available in PDF format

View PDF (Polish) Download PDF file

References

  1. Sepúlveda C, Marlin A, Yoshida T, et al. Palliative Care: the World Health Organization's global perspective. J Pain Symptom Manage. 2002; 24(2): 91–96.
  2. Zalecenia Polskiego Towarzystwa Chorób Płuc dotyczące opieki paliatywnej w przewlekłych chorobach płuc. Pneumonol Aler Pol. 2012; 80: 41–64.
  3. goldcopd.org/wpcontent/uploads/dlm_uploads/.../GOLD_Pocket_2015_Polish.pdf (26.09.2017).
  4. http://goldcopd.org (26.09.2017).
  5. Connors AF, Dawson NV, Thomas C, et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments). Am J Respir Crit Care Med. 1996; 154(4 Pt 1): 959–967.
  6. Suissa S, Dell'Aniello S, Ernst P. Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality. Thorax. 2012; 67(11): 957–963.
  7. Curtis JR, Curtis JR, Engelberg RA, et al. Patient-physician communication about end-of-life care for patients with severe COPD. Eur Respir J. 2008; 32: 796–803.
  8. Vestbo J, Prescott E, Almdal T, et al. Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study. Am J Respir Crit Care Med. 2006; 173(1): 79–83.
  9. Cooper CB, Waterhouse J, Howard P. Twelve year clinical study of patients with hypoxic cor pulmonale given long term domiciliary oxygen therapy. Thorax. 1987; 42(2): 105–110.
  10. Nizet TAC, van den Elshout FJJ, Heijdra YF, et al. Survival of chronic hypercapnic COPD patients is predicted by smoking habits, comorbidity, and hypoxemia. Chest. 2005; 127(6): 1904–1910.
  11. Vieira PJC, Chiappa AM, Cipriano G, et al. Neuromuscular electrical stimulation improves clinical and physiological function in COPD patients. Respir Med. 2014; 108(4): 609–620.
  12. Neder JA, Sword D, Ward SA, et al. Home based neuromuscular electrical stimulation as a new rehabilitative strategy for severely disabled patients with chronic obstructive pulmonary disease (COPD). Thorax. 2002; 57(4): 333–337.
  13. Jassem E, Damps-Konstańska I. Rola specjalisty medycyny paliatywnej w leczeniu chorych na przewlekłą obturacyjną chorobę płuc. Med Paliat Prakt 2014; 8. ; 4: 152–156.
  14. Maddocks M, Lovell N, Booth S, et al. Palliative care and management of troublesome symptoms for people with chronic obstructive pulmonary disease. Lancet. 2017; 390(10098): 988–1002.
  15. Houben CHM, Spruit MA, Schols JM, et al. Instability of Willingness to Accept Life-Sustaining Treatments in Patients With Advanced Chronic Organ Failure During 1 Year. Chest. 2017; 151(5): 1081–1087.